Clinical Trials Directory

Trials / Completed

CompletedNCT01157676

Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
350 (actual)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multi-institutional, randomized trial evaluating oncologic, perioperative, and functional outcomes following two standard care procedures for radical cystectomy. The participants will have one of the standard care procedures as part of their care. The two procedures that will be followed are open radical cystectomy and robotic assisted radical cystectomy (RARC). Open cystectomy is considered to be the more traditional approach. While newer, RARC is considered to be equivalent to open surgery when it is performed by a trained robotics surgeon. The reported complication rates of RARC appear comparable to open surgery. This means there is no significant difference in the risk between the two standard procedures. However, despite these potential advantages, true comparison between the open and robotic technique with regards to long term cancer related and functional outcomes has not been accomplished because previous studies did not compare patients of equal health status. The researchers hope to learn whether or not patients undergoing RARC recover more quickly than or at the same rate as patients undergoing an open radical cystectomy while having non inferior cancer related outcomes. This study is funded by the National Institutes of Health (NIH).

Conditions

Interventions

TypeNameDescription
PROCEDUREOpen radical cystectomyStandard of care removal of urinary bladder.
PROCEDURERobotic assisted radical cystectomyStandard of care removal of urinary bladder using DaVinci robot.
DEVICEDaVinci robotDaVinci robotic surgical system.

Timeline

Start date
2011-07-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2010-07-07
Last updated
2020-11-03
Results posted
2020-01-13

Locations

16 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01157676. Inclusion in this directory is not an endorsement.